Belgium· BE-AMP-SAM575173-00

MenQuadfi

A meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen, konjugiert product containing neisseria meningitidis a+c+w+y, polysaccharides conjugated to tetanus toxoid as a carrier, registered in Belgium by Sanofi Winthrop Industrie. The same ATC class is registered in 11 of our 19 countries.

ATC J07AH08

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedMenQuadfiATCJ07AH08REGISTER NO.BE-AMP-SAM575173-00PACKS LISTED0CHECKEDSeptember 26, 2026

Where it is registered

Meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen, konjugiert is registered in 11 of 19 countries.

Countries holding a registration under ATC J07AH08 (meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen, konjugiert), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen, konjugiert · ATC J07AH08

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Neisseria Meningitidis A+C+W+Y, Polysaccharides conjugated to tetanus toxoid as a carrier
Manufacturer
Sanofi Winthrop Industrie
Country
Belgium (BE)
ATC code
J07AH08
ATC class
Meningokokken A, C, Y, W-135, tetravalent, gereinigtes Polysaccharid-Antigen, konjugiert
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6695debf-c869-48b9-a4e2-4054ce74009e
GET /v1/drugs/6695debf-c869-48b9-a4e2-4054ce74009e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "MenQuadfi",
  "name_fr": "MenQuadfi",
  "name_nl": "MenQuadfi",
  "amp_code": "SAM575173-00",
  "strengths": null,
  "pack_count": 4,
  "substances": [
    "Neisseria Meningitidis A+C+W+Y, Polysaccharides conjugated to tetanus toxoid as a carrier",
    "Sodium Acetate",
    "Sodium Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated",
  "authorisation_numbers": [
    "EU/1/20/1483/001",
    "EU/1/20/1483/002",
    "EU/1/20/1483/003",
    "EU/1/20/1483/004"
  ]
}

See everything about meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen, konjugiert.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.